13.1 Methamphetamine Use Disorder: Pharmacology, Medical & Psychiatric Sequelae
Key Takeaways
- Methamphetamine has an elimination half-life of roughly 10 to 12 hours, against about 1 hour for cocaine, which explains its far longer intoxication, binge-crash pattern and prolonged psychosis risk.
- Methamphetamine-associated cardiomyopathy is a leading cause of heart failure in adults under 50 who use methamphetamine, and left ventricular function can improve substantially with sustained abstinence.
- Methamphetamine-induced psychosis presents with persecutory delusions and tactile hallucinations (formication) in a clear sensorium, which distinguishes it from delirium.
- Hyperthermia above 40 degrees Celsius is the strongest predictor of death in acute methamphetamine toxicity, and external cooling plus benzodiazepine sedation precede all other interventions.
- Beta-blocker monotherapy is avoided in acute methamphetamine or cocaine toxicity because of the theoretical risk of unopposed alpha stimulation; benzodiazepines are the first-line agent for agitation, tachycardia and hypertension.
13.1 Methamphetamine Use Disorder: Pharmacology, Medical & Psychiatric Sequelae
Quick Answer: Methamphetamine reverses the dopamine transporter and VMAT2, forcing non-vesicular dopamine efflux. Its elimination half-life of about 10 to 12 hours (versus roughly 1 hour for cocaine) produces intoxication lasting 8 to 24 hours, multi-day binges, and psychosis that can outlast drug clearance. Cardinal complications are methamphetamine-associated cardiomyopathy, pulmonary arterial hypertension, intracranial hemorrhage, hyperthermia, rhabdomyolysis, and methamphetamine-induced psychosis with formication. Acute toxicity is treated with benzodiazepines plus aggressive external cooling; beta-blocker monotherapy is avoided.
Stimulant use disorder is 15% of the CARN-AP blueprint (22–24 items), and the 2025 practice analysis found time spent with stimulant-using patients had risen from 9.69% to 15.74% of APRN practice — the largest shift in the entire survey.
1. Pharmacologic Contrast With Cocaine
| Feature | Cocaine | Methamphetamine |
|---|---|---|
| Primary mechanism | Blocks DAT, NET, SERT reuptake | Reverses DAT and disrupts VMAT2; also inhibits MAO |
| Elimination half-life | About 1 hour (benzoylecgonine metabolite 6+ hours) | About 10 to 12 hours |
| Duration of subjective effect | 20 to 90 minutes depending on route | 8 to 24 hours |
| Local anesthetic/sodium channel effect | Yes — contributes to wide-complex dysrhythmia | No |
| Typical use pattern | Frequent redosing within a session | Multi-day binge followed by a crash lasting days |
| Neurotoxicity | Primarily vascular | Dopaminergic and serotonergic terminal damage; microglial activation |
Exam trap: because cocaine blocks fast sodium channels, a wide-complex dysrhythmia in cocaine toxicity is treated with sodium bicarbonate. Methamphetamine has no sodium-channel effect, so a wide QRS in a methamphetamine presentation should prompt a search for a co-ingestant or an alternate cause.
2. Cardiovascular Consequences
- Methamphetamine-associated cardiomyopathy (MAC). Catecholamine excess, oxidative stress, mitochondrial injury and repeated ischemia produce a dilated cardiomyopathy that now accounts for a substantial share of heart failure admissions in adults under 50 in high-prevalence regions. Presents as dyspnea, orthopnea, edema and reduced ejection fraction. Left ventricular function can improve markedly with sustained abstinence, which makes this one of the most powerful teaching points available to the APRN: the heart failure is partly reversible, and the medication that treats it best is abstinence combined with guideline-directed heart failure therapy.
- Acute coronary syndrome. Coronary vasospasm plus accelerated atherosclerosis and a prothrombotic state. Chest pain in a methamphetamine-using patient is evaluated as ACS, not dismissed as anxiety.
- Pulmonary arterial hypertension. Methamphetamine is an established cause; screen with echocardiography when unexplained dyspnea or right heart findings appear.
- Aortic dissection and intracranial hemorrhage. Driven by surges of severe hypertension. A methamphetamine-using patient with the worst headache of their life needs imaging, not reassurance.
- Dysrhythmia. Sinus tachycardia is typical; QTc prolongation occurs and matters when methadone or antipsychotics are co-prescribed.
3. Neurologic, Dental, Dermatologic and Infectious Complications
| System | Finding | Mechanism and teaching |
|---|---|---|
| Neurocognitive | Deficits in episodic memory, executive function, processing speed | Dopaminergic terminal injury; substantially improves over 12 or more months of abstinence, though not always to baseline |
| Movement | Choreoathetoid movements, bruxism, punding (repetitive purposeless activity) | Striatal dopamine excess |
| Dental | "Meth mouth" — rampant caries, especially at the gumline | Xerostomia, bruxism, acidic drinks, poor hygiene during binges; not a direct caustic effect of smoked drug |
| Dermatologic | Excoriations on face and forearms | Formication (tactile hallucination of insects under the skin) plus punding; secondary staphylococcal infection is common |
| Infectious | HIV, HCV, invasive staphylococcal disease, syphilis | Injection practice plus sexualized use ("party and play"); screen at every encounter |
| Obstetric | Placental abruption, growth restriction, preterm birth | Vasoconstriction |
4. Methamphetamine-Induced Psychosis
- Presentation: persecutory delusions, auditory hallucinations, and tactile hallucinations (formication), typically in a clear sensorium with intact orientation.
- Distinguishing from delirium: delirium has a fluctuating level of consciousness, disorientation and inattention. A methamphetamine-using patient who is fully oriented, attentive, and describing bugs under the skin has psychosis, not delirium — though hyperthermia and hyponatremia can produce a superimposed delirium.
- Distinguishing from primary schizophrenia: methamphetamine-induced psychosis usually resolves within days to weeks of abstinence and is not typically accompanied by prominent negative symptoms or a prodrome. Persistence beyond about a month of verified abstinence should prompt reconsideration of a primary psychotic disorder. Sensitization means psychosis can recur at lower doses and, in some patients, persist for months.
- Management: benzodiazepines first for agitation. Antipsychotics are used when psychosis is severe or persists; olanzapine and haloperidol have the best evidence, with attention to QTc and to the risk of impaired heat dissipation in a hyperthermic patient.
5. Acute Toxicity: The Priority Sequence
- Temperature first. Hyperthermia above 40 degrees Celsius is the strongest predictor of death. Undress the patient, apply ice packs to the axillae and groin, use evaporative cooling and cooled intravenous fluids. Antipyretics do not work — this is not a hypothalamic set-point fever.
- Benzodiazepines. Titrated intravenous lorazepam or diazepam simultaneously treat agitation, tachycardia, hypertension, hyperthermia from muscular hyperactivity, and seizure risk.
- Volume and electrolytes. Aggressive intravenous fluids for rhabdomyolysis; check creatine kinase, potassium, creatinine, and sodium (hyponatremia from water intoxication is common at dance events).
- Hypertension refractory to benzodiazepines. Use phentolamine (alpha blockade), nicardipine, or nitroglycerin/nitroprusside. Avoid beta-blocker monotherapy because of the theoretical risk of unopposed alpha-mediated vasoconstriction.
- Do not use physical restraint alone. Restraint without adequate sedation drives continued isometric muscular activity, worsening hyperthermia, rhabdomyolysis and metabolic acidosis, and has been implicated in sudden deaths.
A 34-year-old is brought in agitated and combative after smoking methamphetamine. Rectal temperature is 41.1 degrees Celsius, heart rate 148, blood pressure 198/112, and creatine kinase is markedly elevated. Which intervention sequence is most appropriate?
A 41-year-old who has smoked methamphetamine daily for eight years is admitted with dyspnea, orthopnea and an ejection fraction of 25% with no coronary disease on angiography. Which statement should the APRN include in patient and family education?
A patient using methamphetamine presents with persecutory delusions and a vivid sensation of insects crawling under the skin. He is fully alert, oriented to person, place, time and situation, and attends well to the interview. How should the APRN characterize this presentation?